Investing Profile

Genghis Lloyd-Harris

InvestorVC
Partner at Abingworth
Photo of Genghis Lloyd-Harris, Partner at Abingworth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Abingworth Partner
$15.0M - $30.0M
$22.5M
9
$465M
CompanyStageDateRound SizeTotal Raised
Nouscom
Series BNov 2017$49M
$140M
Co-investors: Scott Rocklage (5am Ventures), Guido Magni (Versant Ventures), Hakan Goker (M Ventures (Merck)), Sofia Ioannidou (Andera Partners), Joachim Rothe (EQT Life Sciences)
GenSight Biologics
Series BJul 2015$36M
Series AApr 2013$42M
$130M
Co-investors: Cedric Moreau (Soffinova Partners), Guido Magni (Versant Ventures)
Wilson Therapeutics
Series BApr 2014$40M
$40M
Co-investors: Marten Steen (HealthCap), Bali Muralidhar (Abingworth)
Syntaxin
Series CNov 2010$29M
Series BOct 2007$32M
Series ANov 2005$10M
$71M
Co-investors: Deborah Harland (SR One), René Kuijten (EQT Life Sciences)
Synosia Therapeutics
Series BJan 2009$29M
Series UnknownJan 2007$33M
$92M
Co-investors: Heath Lukatch (Red Tree Venture Capital)